Commonly used reporting guidelines
| STROBE | Observational Studies |
| PRISMA | Systematic reviews of trials |
| PRISMA-P | Systematic review protocols |
| CONSORT | Randomised trials |
| SPIRIT | Randomised trial protocols |
| SRQR | Qualitative Research |
| CARE | Case Reports |
| STARD | Diagnostic studies |
| TRIPOD+AI | Prediction Models |
| ARRIVE | Animal Research |
| SQUIRE | Quality Improvement |
| CHEERS | Economic Evaluations |
| Search all |
Full bibliographic reference
Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, Rycroft-Malone J, Meissner P, Murray E, Patel A, Sheikh A, Taylor SJC, for the StaRI group. Standards for Reporting Implementation Studies (StaRI) statement. BMJ. 2017;356:i6795.
Language
English
Relevant more generic / specialised reporting guidelines (i.e. main generic guideline or extension to a generic guideline)
Specialised
RIMES-SE: Smith MY, Morrato EH, Mora N, Nguyen V, Pinnock H, Winterstein AG. The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE). Drug Saf. 2024. PMID: 38478350
Study design
Clinical trials, Economic evaluations, Experimental studies, Mixed methods studies, Observational studies, Qualitative research, Quality improvement studies
Applies to the whole report or to individual sections of the report?
Whole report
Other
Read a guide (PDF) to reporting guidelines relevant to implementation studies developed by researchers in the Centre for Implementation Science at King’s College London and King’s Improvement Science and led by the National Institute for Health Research Applied Research Collaboration South London (NIHR ARC South London) at King’s College Hospital NHS Foundation Trust and supported by King’s Improvement Science.
Additional information
Read the StaRI guideline development proposal document (PDF).
Record last updated on
June 12, 2024